*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ The/DT Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP ]
approved/VBD 
[ an/DT anti-psychotic/JJ drug/NN ]
made/VBN by/IN 
[ a/DT Sandoz/NNP Ltd./NNP unit/NN ]
to/TO treat/VB 
[ severe/JJ schizophrenia/NN ]
in/IN 
[ patients/NNS ]

[ who/WP ]
do/VBP n't/RB respond/VB to/TO currently/RB 
[ available/JJ drugs/NNS ]
./. 

======================================

[ Some/DT 200,000/CD people/NNS ]
in/IN 
[ the/DT U.S./NNP ]
are/VBP 
[ candidates/NNS ]
for/IN 
[ the/DT drug/NN ]
,/, called/VBN 
[ clozapine/NN ]
,/, 
[ the/DT FDA/NNP ]
said/VBD ./. 

[ Sandoz/NNP Pharmaceutical/NNP Corp./NNP ]
,/, 
[ a/DT subsidiary/NN ]
of/IN 
[ the/DT Swiss/JJ pharmaceutical/JJ giant/NN ]
,/, will/MD make/VB 
[ the/DT drug/NN ]
in/IN 
[ the/DT U.S./NNP ]
and/CC begin/VB marketing/VBG 
[ it/PRP ]
under/IN 
[ the/DT brand/NN name/NN Clozaril/NNP ]
on/IN 
[ Feb./NNP 1/CD ]
./. 

======================================

[ FDA/NNP officials/NNS ]
said/VBD 
[ that/DT clozapine/NN ]
is/VBZ n't/RB 
[ a/DT cure/NN ]
,/, but/CC may/MD help/VB 
[ many/JJ ]
previously/RB 
[ unresponsive/JJ patients/NNS ]
to/TO live/VB more/RBR satisfying/JJ and/CC 
[ productive/JJ lives/NNS ]
./. 

======================================

[ Clozapine/NNP ]
is/VBZ 
[ the/DT ]
first/JJ 
[ anti-psychotic/JJ drug/NN ]
to/TO win/VB 
[ FDA/NNP approval/NN ]
in/IN 
[ 20/CD years/NNS ]
,/, according/VBG to/TO 
[ Sandoz/NNP Pharmaceutical/NNP ]
./. 

Because/IN 
[ the/DT drug/NN ]
can/MD produce/VB 
[ a/DT blood/NN disorder/NN ]
called/VBD 
[ agranulocytosis/NN ]
,/, 
[ the/DT ]
approved/VBN labeling/NN says/VBZ 
[ it/PRP ]
should/MD be/VB prescribed/VBN only/RB for/IN 
[ patients/NNS ]

[ who/WP ]
fail/VBP to/TO respond/VB to/TO 
[ two/CD other/JJ less-toxic/JJ therapies/NNS ]
./. 

======================================

In/IN 
[ addition/NN ]
,/, 
[ the/DT company/NN ]
agreed/VBD to/TO 
[ a/DT unique/JJ testing/NN program/NN ]
to/TO monitor/VB 
[ patients/NNS ]
once/IN 
[ a/DT week/NN ]
for/IN 
[ agranulocytosis/NN ]
,/, 
[ a/DT ]
potentially/RB 
[ fatal/JJ reduction/NN ]
in/IN 
[ white/JJ blood/NN cells/NNS ]

[ that/WDT ]
are/VBP needed/VBN to/TO ward/VB off/RP 
[ infections/NNS ]
./. 

About/RB 
[ 1/CD %/NN ]
of/IN 
[ the/DT patients/NNS ]
on/IN 
[ clozapine/NN ]
develop/VBP 
[ the/DT blood/NN disorder/NN ]
./. 

======================================

``/`` 
[ The/DT severity/NN ]
and/CC 
[ hopelessness/NN ]
of/IN 
[ unremitting/JJ chronic/JJ schizophrenia/NN ]
was/VBD 
[ an/DT important/JJ factor/NN ]
in/IN 
[ the/DT decision/NN ]
to/TO approve/VB 
[ clozapine/NN ]
,/, ''/'' 
[ FDA/NNP Commissioner/NNP Frank/NNP Young/NNP ]
said/VBD ./. 

Without/IN 
[ effective/JJ treatment/NN ]
,/, 
[ schizophrenia/NN ]
can/MD be/VB incapacitating/JJ ./. 

[ Many/JJ patients/NNS ]
live/VBP in/IN 
[ constant/JJ fear/NN ]
and/CC 
[ distress/NN ]
,/, haunted/VBN by/IN 
[ hallucinations/NNS ]
and/CC 
[ delusions/NNS ]
./. 

======================================

Under/IN 
[ the/DT testing/NN program/NN ]
,/, 
[ a/DT home/NN health-care/NN unit/NN ]
of/IN 
[ Baxter/NNP Health/NNP Care/NNP Corp./NNP ]
will/MD deliver/VB 
[ the/DT prescribed/JJ clozapine/NN tablets/NNS ]
to/TO 
[ patients/NNS ]

[ each/DT week/NN ]
and/CC collect/VB 
[ blood/NN samples/NNS ]
for/IN 
[ analysis/NN ]
at/IN 
[ a/DT national/JJ laboratory/NN ]
./. 

If/IN 
[ the/DT white/JJ blood-cell/NN count/NN ]
of/IN 
[ any/DT patients/NNS ]
drops/VBZ ,/, 
[ they/PRP ]
will/MD be/VB taken/VBN off/IN 
[ the/DT drug/NN ]
./. 

======================================

``/`` 
[ There/EX ]
is/VBZ n't/RB really/RB 
[ any/DT ]
 
{/( 
[ program/NN ]
 }/) quite/RB like/IN 
[ this/DT ]
,/, ''/'' said/VBD 
[ David/NNP Winter/NNP ]
of/IN 
[ the/DT Sandoz/NNP unit/NN ]
,/, 
[ East/NNP Hanover/NNP ]
,/, 
[ N.J/NNP ]
./. 

``/`` 
[ We/PRP ]
think/VBP 
[ it/PRP ]
's/VBZ necessary/JJ for/IN 
[ patient/NN safety/NN ]
./. 

''/'' 
[ The/DT drug/NN ]
also/RB is/VBZ associated/VBN with/IN 
[ a/DT high/JJ risk/NN ]
of/IN 
[ seizures/NNS ]
./. 

But/CC 
[ Dr./NNP Winter/NNP ]
said/VBD that/IN 
[ seizures/NNS ]
can/MD be/VB stopped/VBN by/IN reducing/VBG 
[ the/DT dosage/NN ]
./. 

======================================

[ Currently/NNP ]
,/, 
[ Sandoz/NNP ]
makes/VBZ and/CC markets/VBZ 
[ clozapine/NN ]
under/IN 
[ the/DT brand/NN name/NN Leponex/NNP ]
in/IN 
[ Europe/NNP ]
,/, 
[ Dr./NNP Winter/NNP ]
said/VBD ,/, but/CC because/IN of/IN 
[ the/DT potential/JJ side/JJ effects/NNS ]
,/, 
[ its/PRP$ distribution/NN ]
is/VBZ under/IN 
[ strict/JJ control/NN ]
./. 

======================================

[ The/DT development/NN ]
of/IN 
[ clozapine/NN ]
as/IN 
[ an/DT anti-psychotic/JJ drug/NN ]
was/VBD largely/RB abandoned/VBN in/IN 
[ the/DT mid-1970s/NNS ]
after/IN 
[ it/PRP ]
was/VBD found/VBN to/TO cause/VB 
[ agranulocytosis/NN ]
,/, according/VBG to/TO 
[ FDA/NNP officials/NNS ]
./. 

But/CC 
[ occasional/JJ reports/NNS ]
of/IN 
[ remarkable/JJ results/NNS ]
in/IN previously/RB 
[ unresponsive/JJ patients/NNS ]
prompted/VBD 
[ Sandoz/NNP ]
to/TO seek/VB 
[ FDA/NNP approval/NN ]
for/IN 
[ clozapine/NN ]
in/IN 
[ 1984/CD ]
./. 

======================================

Although/IN 
[ the/DT agency/NN ]
turned/VBD down/RP 
[ the/DT company/NN 's/POS initial/JJ application/NN ]
,/, 
[ it/PRP ]
encouraged/VBD 
[ further/JJ study/NN ]
of/IN 
[ clozapine/NN ]
,/, 
[ the/DT officials/NNS ]
said/VBD ./. 

[ A/DT subsequent/JJ clinical/JJ trial/NN ]
was/VBD deemed/VBN ``/`` 
[ successful/JJ ]
''/'' by/IN 
[ the/DT FDA/NNP ]
./. 

In/IN 
[ that/DT trial/NN ]
,/, 
[ 15/CD cases/NNS ]
of/IN 
[ agranulocytosis/NN ]
were/VBD caught/VBN by/IN 
[ testing/NN ]
and/CC reversed/VBN ./. 
